skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Introduction

Two key marketed drugs, Advair and Symbicort, will face erosion in sales due to the emergence of Breo and other generics emerging from the pipeline. Datamonitor Healthcare has provided an in-depth analysis of key marketed products in the US, Japan, and five major EU markets, including an assessment of product positioning in the face of pipeline competition and an evaluation of clinical and commercial drug attributes.

How will our asthma marketed drugs report benefit you?

  • Gain competitive insight
    Access detailed analyses of key marketed drugs within asthma, including an assessment of product positioning in the face of pipeline competition and an evaluation of commercial and clinical drug attributes to determine competitiveness in the market.
  • Understand market share
    Explore how the emergence of Breo and other generics will affect sales of established drugs such as Advair and Symbicort, allowing you to gain a better understanding of your position within the market.
  • Identify driving forces behind the asthma market
    Examine how novel therapies such as Breo, the first once-daily inhaled corticosteroid/long-acting beta 2 agonist, and Xolair, the only biologic for asthma, are positioned within the market so that you can identify what factors are critical for commercial success.

Key questions answered

  • What clinical trials led to regulatory approval of key marketed brands?
  • What factors will enable marketed brands to resist generic erosion?
  • Will GlaxoSmithKline retain its dominance within the asthma market?
http://http//www.datamonitorhealthcare.com/files/2014/07/Asthma-Marketed-Drugs-18.06.2014-19.pdf

おすすめのニュース&レポート

;

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。